90 related articles for article (PubMed ID: 9484505)
1. A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).
Holschbach MH; Fein T; Krummeich C; Lewis RG; Wutz W; Schwabe U; Unterlugauer D; Olsson RA
J Med Chem; 1998 Feb; 41(4):555-63. PubMed ID: 9484505
[TBL] [Abstract][Full Text] [Related]
2. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
Scammells PJ; Baker SP; Belardinelli L; Olsson RA
J Med Chem; 1994 Aug; 37(17):2704-12. PubMed ID: 8064798
[TBL] [Abstract][Full Text] [Related]
3. New potent A
Kreft S; Bier D; Holschbach MH; Schulze A; Coenen HH
Nucl Med Biol; 2017 Jan; 44():69-77. PubMed ID: 27821347
[TBL] [Abstract][Full Text] [Related]
4. Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A
Schneider D; Oskamp A; Holschbach M; Neumaier B; Bier D; Bauer A
Nucl Med Biol; 2020; 82-83():1-8. PubMed ID: 31838339
[TBL] [Abstract][Full Text] [Related]
5. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
6. 2-substituted thioadenine nucleoside and nucleotide analogues: synthesis and receptor subtype binding affinities (1).
Hasan A; Hussain T; Mustafa SJ; Srivastava PC
Bioconjug Chem; 1994; 5(4):364-9. PubMed ID: 7948104
[TBL] [Abstract][Full Text] [Related]
7. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
[TBL] [Abstract][Full Text] [Related]
8. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.
Liang BT
J Pharmacol Exp Ther; 1989 Jun; 249(3):775-84. PubMed ID: 2732946
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging.
Holschbach MH; Olsson RA; Bier D; Wutz W; Sihver W; Schüller M; Palm B; Coenen HH
J Med Chem; 2002 Nov; 45(23):5150-6. PubMed ID: 12408725
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand.
Noguchi J; Ishiwata K; Furuta R; Simada J; Kiyosawa M; Ishii S; Endo K; Suzuki F; Senda M
Nucl Med Biol; 1997 Jan; 24(1):53-9. PubMed ID: 9080475
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
15. 3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonists.
Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Novellino E; Greco G; Lavecchia A; Trincavelli L; Martini C
J Med Chem; 2001 Feb; 44(3):316-27. PubMed ID: 11462973
[TBL] [Abstract][Full Text] [Related]
16. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
Yan L; Müller CE
J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
[TBL] [Abstract][Full Text] [Related]
17. Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors.
Kristensen JL; Püschl A; Jensen M; Risgaard R; Christoffersen CT; Bang-Andersen B; Balle T
J Med Chem; 2010 Oct; 53(19):7021-34. PubMed ID: 20857909
[TBL] [Abstract][Full Text] [Related]
18. Development of spin-labeled probes for adenosine receptors.
Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
[TBL] [Abstract][Full Text] [Related]
19. In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments.
Elmenhorst D; Kroll T; Wedekind F; Weisshaupt A; Beer S; Bauer A
J Nucl Med; 2013 Aug; 54(8):1411-9. PubMed ID: 23740103
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET).
Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA
Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
